Ayla
Dementia Care
Big global dementia challenges
require smart solutions
An estimated
139 million
will live with dementia by 2050
A new case every
3 seconds
somewhere in the world
Globally,
€9.1 trillion
in healthcare expenditure by 2050
There is, however, a clinically proven way to delay cognitive decline for most patients
We are pioneers of digital Cognitive Stimulation Therapy (CST), the world’s leading non-drug dementia treatment. Alzheimer’s Disease International and the WHO recommend its global implementation and endorsed by the National Institute for Health and Care Excellence (NICE) in the UK.
There is, however, a clinically proven way to delay cognitive decline for most patients
We are pioneers of digital Cognitive Stimulation Therapy (CST), the world-leading non-drug dementia treatment recommended for global implementation and endorsed by the National Institute for health and Care Excellence (NICE) in the UK.
Cognitive Stimulation Therapy (CST) results in
4-6 months delay in cognitive decline
Enhanced communication and language skills
Improved confidence and quality of life
Meet Ayla
your CST Assistant
Our first Ayla Dementia Care platform product. Offers accessible, customizable and expertly validated digital CST to support standardized high quality treatment delivery.
14 fullCST sessions
- 180+ expertly validated CST activities
- Cognitively stimulating and demographically suitable
- Digital guidance through a session
Easily
adaptable
- Adaptable content ensure maximum stimulation and engagement
- Easy-to-use filters based on cognitive and physical ability of patients
- Additional printable material and tips for best practice
Clinically
relevant
- Standardized approach to enhance patient outcomes
- Reduction in preparation time by 50%*
- Equivalent patient outcomes to CST
*based on DK and AgeUK usability study
Ayla for healthcare providers
Learn how Ayla can help you and your organisation offer engaging, adaptable and clinically relevant Cognitive Stimulation Therapy (CST)
Ayla for patients and carers
Help us in the development of our Home Companion, the first product directly aimed to help people with dementia. The Home Companion will assist you or a loved one in cognitive stimulation and living with dementia.
Ayla for investors
Stay updated on Brain+ company releases, financials and corporate actions as we build our digital dementia care platform.
